{"id":"https://openalex.org/W4361944448","doi":"https://doi.org/10.1158/1078-0432.c.6521997","title":"Data from Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer","display_name":"Data from Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361944448","doi":"https://doi.org/10.1158/1078-0432.c.6521997"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6521997","doi":"https://doi.org/10.1158/1078-0432.c.6521997","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521997","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6521997","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110480128","display_name":"Christine E. Horak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine E. Horak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021113979","display_name":"Lajos Pusztai","orcid":"https://orcid.org/0000-0001-9632-6686","observed_orcids":["https://orcid.org/0000-0001-9632-6686"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lajos Pusztai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081758381","display_name":"Guan Xing","orcid":"https://orcid.org/0000-0001-6011-3267","observed_orcids":["https://orcid.org/0000-0001-6011-3267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guan Xing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109050994","display_name":"Ovidiu C. Trifan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ovidiu C. Trifan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082195410","display_name":"Cristina Saura","orcid":"https://orcid.org/0000-0001-8296-5065","observed_orcids":["https://orcid.org/0000-0001-8296-5065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Saura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055292882","display_name":"Ling\u2010Ming Tseng","orcid":"https://orcid.org/0000-0002-4648-6646","observed_orcids":["https://orcid.org/0000-0002-4648-6646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ling-Ming Tseng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056471340","display_name":"Stephen Y.T. Chan","orcid":"https://orcid.org/0000-0001-8865-6618","observed_orcids":["https://orcid.org/0000-0001-8865-6618","https://orcid.org/0000-0001-8998-5480"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043714971","display_name":"Rosanne Welcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosanne Welcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"David Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9779999852180481},{"id":"https://openalex.org/keywords/ixabepilone","display_name":"ixabepilone","score":0.9819999933242798},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/doxorubicin-and-cyclophosphamide","display_name":"doxorubicin-cyclophosphamide","score":0.9509999752044678},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8270000219345093},{"id":"https://openalex.org/keywords/beta-iii-tubulin","display_name":"TUBB3","score":0.890999972820282},{"id":"https://openalex.org/keywords/tacc3","display_name":"TACC3","score":1.0},{"id":"https://openalex.org/keywords/capg","display_name":"CAPG","score":0.9570000171661377},{"id":"https://openalex.org/keywords/gene-expression-models","display_name":"gene expression models","score":0.7080000042915344},{"id":"https://openalex.org/keywords/estrogen-receptor-negative-breast-cancer","display_name":"estrogen receptor-negative breast cancer","score":0.8690000176429749},{"id":"https://openalex.org/keywords/molecular-subtyping","display_name":"molecular subtyping","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2779194965","wikidata":"https://www.wikidata.org/wiki/Q11711607","display_name":"Ixabepilone","level":5,"score":0.8383260369300842},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6233497858047485},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6061323881149292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5795444846153259},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5241929888725281},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.49924635887145996},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49470254778862},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.4681095778942108},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4523119628429413},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.44207024574279785},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.424924373626709},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3647022247314453},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3361956775188446},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19595807790756226},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.1433342695236206},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6521997","doi":"https://doi.org/10.1158/1078-0432.c.6521997","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521997","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6521997","doi":"https://doi.org/10.1158/1078-0432.c.6521997","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521997","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2132144873","https://openalex.org/W2099734281","https://openalex.org/W2321039541","https://openalex.org/W6983725800","https://openalex.org/W4235249871","https://openalex.org/W120747790","https://openalex.org/W2144099154","https://openalex.org/W2562589372","https://openalex.org/W2320235510","https://openalex.org/W4234869569"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Predictive":[2],"biomarkers":[3,41],"offer":[4],"the":[5,9,29,131,156,198,206],"potential":[6,40,106],"to":[7,24,38,45,66,119],"improve":[8],"benefit:risk":[10],"ratio":[11],"of":[12,77,108,130,158,200],"a":[13,95,126],"therapeutic":[14],"agent.":[15,47],"Ixabepilone":[16],"achieves":[17],"comparable":[18],"pathologic":[19],"complete":[20],"response":[21,44],"(pCR)":[22],"rates":[23,169],"other":[25,105],"active":[26],"drugs":[27],"in":[28,155,160,164,176,247],"neoadjuvant":[30,60],"setting.":[31],"This":[32],"phase":[33],"II":[34],"trial":[35],"was":[36,151,182],"designed":[37],"investigate":[39],"that":[42,214],"differentiate":[43],"this":[46],"Experimental":[48],"Design:":[49],"Women":[50],"with":[51],"untreated,":[52],"histologically":[53],"confirmed":[54],"primary":[55,132],"invasive":[56],"breast":[57,249],"adenocarcinoma":[58],"received":[59],"doxorubicin/cyclophosphamide,":[61],"followed":[62],"by":[63],"1:1":[64],"randomization":[65],"ixabepilone":[67,201,244],"(n":[68,73],"=":[69,74],"148)":[70],"or":[71,202],"paclitaxel":[72,246],"147).":[75],"Rates":[76],"pCR":[78,159,168],"were":[79,144,170],"compared":[80],"between":[81,184,243],"treatment":[82,162,241],"arms":[83,163],"based":[84],"on":[85],"predefined":[86],"biomarker":[87],"sets:":[88],"TUBB3,":[89,185],"TACC3,":[90,186],"and":[91,97,104,187,197,217,224,228,233,245],"CAPG":[92,188,225],"gene":[93,189,226],"expression,":[94,103,190,193,219,222,227],"20-":[96],"26-gene":[98],"expression":[99,112,141,195,230],"model,":[100],"MDR1":[101,191,220],"protein":[102,111,192,216,221],"markers":[107,238],"sensitivity.":[109],"\u03b2III-tubulin":[110,215],"is":[113,117],"reported":[114],"separately":[115],"but":[116],"referred":[118],"here":[120],"for":[121,134,146,239],"completeness.":[122],"All":[123],"patients":[124,174],"underwent":[125],"core":[127],"needle":[128],"biopsy":[129],"cancer":[133],"molecular":[135,147],"marker":[136],"analysis":[137],"before":[138],"chemotherapy.":[139],"Gene":[140],"profiling":[142],"data":[143],"used":[145],"subtyping.":[148],"Results:":[149],"There":[150],"no":[152,180],"significant":[153],"difference":[154],"rate":[157],"both":[161],"\u03b2III-tubulin\u2013positive":[165,173],"patients.":[166,178],"Higher":[167],"observed":[171],"among":[172],"than":[175],"\u03b2III-tubulin\u2013negative":[177],"Furthermore,":[179],"correlation":[181],"evident":[183],"multi-gene":[194],"models,":[196],"efficacy":[199],"paclitaxel,":[203],"even":[204],"within":[205],"estrogen":[207],"receptor\u2013negative":[208],"subset.":[209],"Conclusion:":[210],"These":[211],"results":[212],"indicate":[213],"mRNA":[218],"TACC3":[223],"multigene":[229],"models":[231],"(20-":[232],"26-gene)":[234],"are":[235],"not":[236],"predictive":[237],"differentiating":[240],"benefit":[242],"early-stage":[248],"cancer.":[250],"Clin":[251],"Cancer":[252],"Res;":[253],"19(6);":[254],"1587\u201395.":[255],"\u00a92013":[256],"AACR.":[257]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-05T00:00:00"}